CYP cynata therapeutics limited

CYP Price Target post MSB FDA approval., page-275

  1. 181 Posts.
    lightbulb Created with Sketch. 63
    Hot off the press presentation by KK on youtube - Progress, Potential, and Possibilities podcast.

    Don't think this has been posted.

    Dr. Kilian Kelly, Ph.D. - CEO, Cynata Therapeutics - iPSC-Derived, Mesenchymal Stem Cell Therapies
    https://youtu.be/FeVZEh5Yv9E?si=9Kt8WRb7AAdS6awc

    VFM
    Last edited by Valueformoney: 08/04/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $37.28M
Open High Low Value Volume
16.5¢ 17.0¢ 16.5¢ $39.66K 238.2K

Buyers (Bids)

No. Vol. Price($)
5 277684 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 14285 1
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.